Announce Date | 09/01/2015 |
EPS Normalized Actual | $0.06 In Line |
EPS GAAP Actual | $0.06 In Line |
Revenue Actual | $4.0759B |
Revenue Surprise | Beat by $4075.9M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2028 | 27.03724 | 1.06 | 25.5909 | 28.42017 | 1 |
Jun 2027 | 22.08741 | 1.3 | 22.08741 | 22.08741 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 14.8 | 14.8 | 4.0759B | 95.72% | 4075.9M |
FQ1 2024 (Mar 2024) | 4.29 | 2.71355 | 1.63275B | 100% | -18246M |
FQ3 2024 (Sep 2024) | 5.6 | 4.05859 | 1.90115B | 100% | -20070.1M |
FQ4 2024 (Dec 2024) | 5.6 | -33.34988 | 1.90115B | 100% | -1539.08M |
FQ3 1996 (Sep 1996) | -0.18 | -0.18 | 0.0698606B | 100% | 69.86M |
FQ4 1996 (Dec 1996) | -0.19 | -0.19 | 0.0720258B | 100% | 72.03M |
FQ1 1997 (Mar 1997) | -0.18 | -0.18 | 0.0681219B | 100% | 68.12M |
FQ2 1997 (Jun 1997) | -0.25 | -0.25 | 0.0745368B | 100% | 74.54M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 26.93429 | -- | 26.93429 | 26.93429 | 1 |
FQ3 2027 (Sep 2027) | 24.38399 | -- | 24.38399 | 24.38399 | 1 |
FQ1 2027 (Mar 2027) | 39.43565 | -- | 39.43565 | 39.43565 | 1 |
FQ4 2026 (Dec 2026) | 26.45345 | -- | 26.45345 | 26.45345 | 1 |
FQ3 2026 (Sep 2026) | 22.30657 | -- | 22.30657 | 22.30657 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.6B | -- | 2.6B | 2.6B | 1 |
FQ3 2027 (Sep 2027) | 6.31B | -- | 6.31B | 6.31B | 1 |
FQ1 2027 (Mar 2027) | 2.4B | -- | 2.4B | 2.4B | 1 |
FQ4 2026 (Dec 2026) | 2.34B | -- | 2.34B | 2.34B | 1 |
FQ3 2026 (Sep 2026) | 2.28B | -- | 2.28B | 2.28B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 14.8 | 14.8 | 100% | |
FQ1 2024 (Mar 2024) | 1.57645 | 4.29 | 2.71355 | 63.25% |
FQ3 2024 (Sep 2024) | 1.54141 | 5.6 | 4.05859 | 72.47% |
FQ4 2024 (Dec 2024) | 38.94988 | 5.6 | -33.34988 | -595.53% |
FQ3 1996 (Sep 1996) | -0.18 | -0.18 | 100% | |
FQ4 1996 (Dec 1996) | -0.19 | -0.19 | 100% | |
FQ1 1997 (Mar 1997) | -0.18 | -0.18 | 100% | |
FQ2 1997 (Jun 1997) | -0.25 | -0.25 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $4.08B | $4075.9M | 100% |
FQ1 2024 (Mar 2024) | $19.88B | $1.63B | $-18246M | -1117.5% |
FQ3 2024 (Sep 2024) | $21.97B | $1.9B | $-20070.1M | -1055.68% |
FQ4 2024 (Dec 2024) | $3.44B | $1.9B | $-1539.08M | -80.96% |
FQ3 1996 (Sep 1996) | $0B | $0.07B | $69.86M | 100% |
FQ4 1996 (Dec 1996) | $0B | $0.07B | $72.03M | 100% |
FQ1 1997 (Mar 1997) | $0B | $0.07B | $68.12M | 100% |
FQ2 1997 (Jun 1997) | $0B | $0.07B | $74.54M | 100% |